SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-064291
Filing Date
2017-12-06
Accepted
2017-12-06 20:14:06
Documents
2
Period of Report
2017-12-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5270
2 POA DOCUMENT poa.txt EX-24.3_755615 3484
  Complete submission text file 0001209191-17-064291.txt   10011
Mailing Address
Business Address
TIDMARSH GEORGE F (Reporting) CIK: 0001287235 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38318 | Film No.: 171243312

Mailing Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 510 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, LLC (Issuer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations